Mostrar el registro sencillo del ítem

dc.contributor.authorBleriot Rial, Ines Maria
dc.contributor.authorBlasco Otero, Lucía
dc.contributor.authorDelgado-Valverde, Mercedes
dc.contributor.authorGual de Torella, Ana
dc.contributor.authorAmbroa Abalo, Antón
dc.contributor.authorFernández García, Laura
dc.contributor.authorLópez Díaz, María José 
dc.contributor.authorOteo-Iglesias, Jesus
dc.contributor.authorWood, Thomas K
dc.contributor.authorPascual, Alvaro
dc.contributor.authorBou Arévalo, Germán 
dc.contributor.authorFernandez-Cuenca, Felipe
dc.contributor.authorTomás Carmona, María del Mar 
dc.date.accessioned2022-03-16T08:39:28Z
dc.date.available2022-03-16T08:39:28Z
dc.date.issued2020
dc.identifier.issn2072-6651
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/32887507es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/16283
dc.description.abstractAlthough the failure of antibiotic treatment is normally attributed to resistance, tolerance and persistence display a significant role in the lack of response to antibiotics. Due to the fact that several nosocomial pathogens show a high level of tolerance and/or resistance to chlorhexidine, in this study we analyzed the molecular mechanisms associated with chlorhexidine adaptation in two clinical strains of Klebsiella pneumoniae by phenotypic and transcriptomic studies. These two strains belong to ST258-KPC3 (high-risk clone carrying beta-lactamase KPC3) and ST846-OXA48 (low-risk clone carrying beta-lactamase OXA48). Our results showed that the K. pneumoniae ST258-KPC3CA and ST846-OXA48CA strains exhibited a different behavior under chlorhexidine (CHLX) pressure, adapting to this biocide through resistance and tolerance mechanisms, respectively. Furthermore, the appearance of cross-resistance to colistin was observed in the ST846-OXA48CA strain (tolerant to CHLX), using the broth microdilution method. Interestingly, this ST846-OXA48CA isolate contained a plasmid that encodes a novel type II toxin/antitoxin (TA) system, PemI/PemK. We characterized this PemI/PemK TA system by cloning both genes into the IPTG-inducible pCA24N plasmid, and found their role in persistence and biofilm formation. Accordingly, the ST846-OXA48CA strain showed a persistence biphasic curve in the presence of a chlorhexidine-imipenem combination, and these results were confirmed by the enzymatic assay (WST-1).en
dc.rightsAtribución 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshDrug Combinations*
dc.subject.meshImipenem*
dc.subject.meshTime Factors*
dc.subject.meshDrug Tolerance*
dc.subject.meshChlorhexidine*
dc.subject.meshAnti-Bacterial Agents*
dc.subject.meshAnti-Infective Agents*
dc.subject.meshBacterial Proteins*
dc.subject.meshbeta-Lactamases*
dc.subject.meshKlebsiella pneumoniae*
dc.titleMechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of Klebsiella pneumoniae Producers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK.en
dc.typeJournal Articlees
dc.authorsophosBleriot, Ines;Blasco, Lucia;Delgado-Valverde, Mercedes;Gual de Torella, Ana;Ambroa, Anton;Fernandez-Garcia, Laura;Lopez, Maria;Oteo-Iglesias, Jesus;Wood, Thomas K;Pascual, Alvaro;Bou, German;Fernandez-Cuenca, Felipe;Tomas, Maria
dc.identifier.doi10.3390/toxins12090566
dc.identifier.pmid32887507
dc.identifier.sophos36208
dc.issue.number9es
dc.journal.titleToxins (Basel)es
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario de A Coruña::Microbioloxíaes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::Instituto de Investigación Biomédica da Coruña (INIBIC)es
dc.relation.publisherversionhttps://mdpi-res.com/d://attachment/toxins/toxins-12-00566/article://deploy/toxins-12-00566-v2.pdfes
dc.rights.accessRightsopenAccess
dc.subject.decstolerancia a medicamentos*
dc.subject.decsimipenem*
dc.subject.decsbeta-lactamasas*
dc.subject.decsantiinfecciosos*
dc.subject.decsfactores de tiempo*
dc.subject.decsclorhexidina*
dc.subject.decscombinaciones de fármacos*
dc.subject.decsproteínas bacterianas*
dc.subject.decsantibacterianos*
dc.subject.decsKlebsiella pneumoniae*
dc.subject.keywordCHUACes
dc.subject.keywordINIBICes
dc.typefidesArtículo Originales
dc.typesophosArtículo Originales
dc.volume.number12es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional